Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
39 hedge funds and large institutions have $24.2M invested in Ocean Biomedical, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
11% more funds holding
Funds holding: 35 → 39 (+4)
40% less capital invested
Capital invested by funds: $40.6M → $24.2M (-$16.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$455K |
| 2 |
BlackRock
New York
|
+$263K |
| 3 |
Morgan Stanley
New York
|
+$228K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$105K |
| 5 |
State Street
Boston,
Massachusetts
|
+$77.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.39M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$189K |
| 3 |
VF
Virtu Financial
New York
|
-$173K |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$114K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$27.1K |
OCEA Hedge Fund Activity: Q3 2023 in Review
39 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q3 2023, worth a combined $24.2M — down 40% from $40.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new OCEA positions and 2 closed out — a net gain of 4 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was Vanguard Group, adding an estimated $455K. The largest seller was Polar Asset Management Partners, cutting an estimated $3.39M.
- 39 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q3 2023, up from 35 in Q2 2023.
- Funds reported $24.2M of Ocean Biomedical, Inc. Common Stock stock for Q3 2023, down 40% quarter-over-quarter.
- 6 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q3 2023 and 2 closed out, a net change of +4 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q3 2023 was Vanguard Group, an estimated $455K added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q3 2023 was Polar Asset Management Partners, an estimated $3.39M sold.
Based on aggregated 13F filings for Q3 2023.